2014
DOI: 10.1074/jbc.m114.614065
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a Peptide Inhibitor of the RPM-1·FSN-1 Ubiquitin Ligase Complex

Abstract: Background: How RPM-1 interacts with FSN-1 remains unknown. Results: Structure-function and transgenic analysis define the biochemical relationship between RPM-1 and FSN-1. Conclusion: RPM-1 uses a conserved mechanism to bind FSN-1 that is independent of RPM-1 ubiquitin ligase activity. Significance: Our biochemical and genetic analysis has led to identification of RIP, an in vivo inhibitor of the RPM-1⅐FSN-1 ubiquitin ligase complex.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

8
33
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 22 publications
(41 citation statements)
references
References 38 publications
8
33
0
Order By: Relevance
“…This approach revealed two new domains in RPM-1, FBD2 and FBD3, which are sufficient for binding to FSN-1. Because these interactions were not observed previously using 293 cells (24), our results show that binding of FSN-1 to portions of RPM-1 requires in vivo expression in worm neurons. Using a similar approach, we map the RBD to a significantly smaller region in RPM-1 and show that mutations in RPM-1 that reduce binding to RAE-1 do not affect binding to FSN-1.…”
mentioning
confidence: 43%
See 4 more Smart Citations
“…This approach revealed two new domains in RPM-1, FBD2 and FBD3, which are sufficient for binding to FSN-1. Because these interactions were not observed previously using 293 cells (24), our results show that binding of FSN-1 to portions of RPM-1 requires in vivo expression in worm neurons. Using a similar approach, we map the RBD to a significantly smaller region in RPM-1 and show that mutations in RPM-1 that reduce binding to RAE-1 do not affect binding to FSN-1.…”
mentioning
confidence: 43%
“…However, corresponding mutations in full-length RPM-1 did not affect binding to FSN-1 in worm neurons (24). This raised two points: there were likely to be other sites in RPM-1, besides FBD1, that were sufficient for binding to FSN-1, and identification of these sites was likely to require in vivo biochemistry from transgenic C. elegans.…”
Section: Resultsmentioning
confidence: 98%
See 3 more Smart Citations